Evaluation the predictive value of biomarkers for efficacy outcomes in response to pertuzumab and trastuzumab based therapy: An exploratory analysis of the tryphaena study (2014)
- Autores:
- Autor USP: HEGG, ROBERTO - FM
- Unidade: FM
- Assuntos: BIOMARCADORES; ANTINEOPLÁSICOS (APLICAÇÕES TERAPÊUTICAS); CO-TERAPIA; TÉCNICAS BIOLÓGICAS
- Idioma: Inglês
- Imprenta:
- Fonte:
- Título: Breast Cancer Research
- ISSN: 1465-5411
- Volume/Número/Paginação/Ano: v. 16, n. 4, p. R73, 2014
-
ABNT
SCHNEEWEISS, Andrea et al. Evaluation the predictive value of biomarkers for efficacy outcomes in response to pertuzumab and trastuzumab based therapy: An exploratory analysis of the tryphaena study. Breast Cancer Research, v. 16, n. 4, p. R73, 2014Tradução . . Disponível em: http://breast-cancer-research.com/content/pdf/bcr3690.pdf. Acesso em: 18 nov. 2024. -
APA
Schneeweiss, A., Chia, S., Hegg, R., Tausch, C., Deb, R., Ratnayake, J., et al. (2014). Evaluation the predictive value of biomarkers for efficacy outcomes in response to pertuzumab and trastuzumab based therapy: An exploratory analysis of the tryphaena study. Breast Cancer Research, 16( 4), R73. Recuperado de http://breast-cancer-research.com/content/pdf/bcr3690.pdf -
NLM
Schneeweiss A, Chia S, Hegg R, Tausch C, Deb R, Ratnayake J, Mcnally V, Ross G, Kiermaier A, Cortés J. Evaluation the predictive value of biomarkers for efficacy outcomes in response to pertuzumab and trastuzumab based therapy: An exploratory analysis of the tryphaena study [Internet]. Breast Cancer Research. 2014 ; 16( 4): R73.[citado 2024 nov. 18 ] Available from: http://breast-cancer-research.com/content/pdf/bcr3690.pdf -
Vancouver
Schneeweiss A, Chia S, Hegg R, Tausch C, Deb R, Ratnayake J, Mcnally V, Ross G, Kiermaier A, Cortés J. Evaluation the predictive value of biomarkers for efficacy outcomes in response to pertuzumab and trastuzumab based therapy: An exploratory analysis of the tryphaena study [Internet]. Breast Cancer Research. 2014 ; 16( 4): R73.[citado 2024 nov. 18 ] Available from: http://breast-cancer-research.com/content/pdf/bcr3690.pdf - Galactorreia: sindrome hiperprolactinemica
- Como diagnosticar e tratar sindrome do climaterio
- Hormonioterapia de reposicao e cancer de mama
- Prevencao da osteoporose
- Câncer de mama
- Recursos terapêuticos na doente terminal
- Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer
- Everolimus (EVE) plus letrozole (LET) in patients (pts) with estrogen receptor-positive (ER plus ), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer (ABC): Progression-free survival (PFS) subgroup analyses in BOLERO-4
- Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial
- Cancer de ovario
Como citar
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
